Omnicell (OMCL) Tops Q3 EPS by 14c ; Offers Guidance
Get Alerts OMCL Hot Sheet
Price: $34.37 -1.29%
Revenue Growth %: -1.7%
Financial Fact:
Selling, general and administrative: 61.32M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -1.7%
Financial Fact:
Selling, general and administrative: 61.32M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Omnicell (NASDAQ: OMCL) reported Q3 EPS of $0.56, $0.14 better than the analyst estimate of $0.42. Revenue for the quarter came in at $282 million versus the consensus estimate of $280.45 million.
GUIDANCE:
Omnicell sees Q4 2024 EPS of $0.55-$0.62, versus the consensus of $0.47. Omnicell sees Q4 2024 revenue of $295-305 million, versus the consensus of $287.7 million.
Omnicell sees FY2024 EPS of $1.65-$1.72, versus the consensus of $1.43. Omnicell sees FY2024 revenue of $0.8-0.875 billion, versus the consensus of $1.09 billion.
For earnings history and earnings-related data on Omnicell (OMCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
- Jefferies Upgrades DWS Group GmbH & Co KGaA (DWS:GR) to Buy
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share